GALVANI BIOELECTRONICS Trademark

Trademark Overview

On Monday, February 15, 2016, a trademark application was filed for GALVANI BIOELECTRONICS with the United States Patent and Trademark Office. The USPTO has given the GALVANI BIOELECTRONICS trademark a serial number of 86908106. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 19, 2024. This trademark is owned by Glaxo Group Limited. The GALVANI BIOELECTRONICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
galvani bioelectronics

General Information

Serial Number86908106
Word MarkGALVANI BIOELECTRONICS
Filing DateMonday, February 15, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 19, 2024
Registration Number5299056
Registration DateTuesday, October 3, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
NOT AVAILABLE"BIOELECTRONICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGALVANI BIOELECTRONICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type05 - Joint Venture
AddressBRENTFORD, MIDDLESEX TW89GS
GB
Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Thursday, July 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2016NEW APPLICATION ENTERED
Monday, February 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2016ASSIGNED TO EXAMINER
Monday, May 23, 2016NON-FINAL ACTION WRITTEN
Monday, May 23, 2016NON-FINAL ACTION E-MAILED
Monday, May 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 21, 2016ASSIGNED TO LIE
Thursday, July 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 6, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, January 27, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 14, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, August 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 3, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 14, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, August 30, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 19, 2024CANCELLED SEC. 8 (6-YR)
Friday, September 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

bioelectronics galvani pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological